Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior

Frontiers in Neuroscience

Volumn , Issue 7 SEP, 2013, Pages

  Fox, James H ^a   Lowry, Christopher A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Anxiety; Corticotropin releasing factor; Dorsal raphe nucleus; Emotional behavior; Serotonin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; PROTEIN C FOS; SEROTONIN; SEROTONIN RECEPTOR; UROCORTIN I; UROCORTIN II; UROCORTIN III;

ANXIETY; ANXIETY DISORDER; BRAIN REGION; CELL FUNCTION; DORSAL RAPHE NUCLEUS; EMOTION; HUMAN; MICRODIALYSIS; MOOD DISORDER; NERVE CELL NETWORK; NEUROANATOMY; NEUROTRANSMISSION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PROTEIN INTERACTION; REVIEW; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; STRESS;

EID: 84901496570     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2013.00169     Document Type: Review

References (198)

1. Abrams, J. K., Johnson, P. L., Hay-Schmidt, A., Mikkelsen, J. D., Shekhar, A., and Lowry, C. A. (2005). Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience 133, 983-997. doi: 10.1016/j.neuroscience.2005.03.025
2. Altieri, S. C., Garcia-Garcia, A. L., Leonardo, E. D., and Andrews, A. M. (2012). Rethinking 5-HT1A Receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior. ACS Chem. Neurosci. 4, 72-83. doi: 10.1021/cn3002174
3. Alves, S. H., Pinheiro, G., Motta, V., Landeira-Fernandez, J., and Cruz, A. P. (2004). Anxiogenic effects in the rat elevated plus-maze of 5-HT(2C) agonists into ventral but not dorsal hippocampus. Behav. Pharmacol. 15, 37-43. doi: 10.1097/00008877-200402000-00005
4. Amat, J., Baratta, M. V., Paul, E., Bland, S. T., Watkins, L. R., and Maier, S. F. (2005). Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat. Neurosci. 8, 365-371. doi: 10.1038/nn1399
5. Amat, J., Tamblyn, J. P., Paul, E. D., Bland, S. T., Amat, P., Foster, A. C., et al. (2004). Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience 129, 509-519. doi: 10.1016/j.neuroscience.2004.07.052
6. Arató, M., Bánki, C. M., Bissette, G., and Nemeroff, C. B. (1989). Elevated CSF CRF in suicide victims. Biol. Psychiatry 25, 355-359. doi: 10.1016/0006-3223(89)90183-2
7. Asan, E., Steinke, M., and Lesch, K.-P. (2013). Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety. Histochem. Cell Biol. 139, 785-813. doi: 10.1007/s00418-013-1081-1
8. Austin, M. C., Janosky, J. E., and Murphy, H. A. (2003). Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol. Psychiatry 8, 324-332. doi: 10.1038/sj.mp.4001250
9. Azmitia, E. C., and Segal, M. (1978). An autoradiographic analysis of the differential ascending projection of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 179, 651-668. doi: 10.1002/cne.901790311
10. Bach-Mizrachi, H., Underwood, M. D., Kassir, S. A., Bakalian, M. J., Sibille, E., Tamir, H., et al. (2006). Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology 31, 814-824. doi: 10.1038/sj.npp.1300897
11. Bach-Mizrachi, H., Underwood, M. D., Tin, A., Ellis, S. P., Mann, J. J., and Arango, V. (2008). Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides. Mol. Psychiatry 13, 507-513. doi: 10.1038/sj.mp.4002143
12. Bago, M., Marson, L., and Dean, C. (2002). Serotonergic projections to the rostroventrolateral medulla from midbrain and raphe nuclei. Brain Res. 945, 249-258. doi: 10.1016/S0006-8993(02)02811-1
13. Bale, T. L., Contarino, A., Smith, G. W., Chan, R., Gold, L. H., Sawchenko, P. E., et al. (2000). Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 24, 410-414. doi: 10.1038/74263
14. Bale, T. L., Picetti, R., Contarino, A., Koob, G. F., Vale, W. W., and Lee, K.-F. (2002). Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like Behavior. J. Neurosci. 22, 193-199.
15. Barnes, N. M., and Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152. doi: 10.1016/S0028-3908(99)00010-6
16. Beekman, M., Flachskamm, C., and Linthorst, A. C. E. (2005). Effects of exposure to a predator on behaviour and serotonergic neurotransmission in different brain regions of C57bl/6N mice. Eur. J. Neurosci. 21, 2825-2836. doi: 10.1111/j.1460-9568.2005.04107.x
17. Beitz, A. J. (1982). The organization of afferent projections to the midbrain periaqueductal gray of the rat. Neuroscience 7, 133-159. doi: 10.1016/0306-4522(82)90157-9
18. Bethea, C. L., Lima, F. B., Centeno, M. L., Weissheimer, K. V., Senashova, O., Reddy, A. P., et al. (2011). Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity. J. Chem. Neuroanat. 41, 200-218. doi: 10.1016/j.jchemneu.2011.05.010
19. Bethea, C. L., Pau, F. K. Y., Fox, S., Hess, D. L., Berga, S. L., and Cameron, J. L. (2005a). Sensitivity to stress-induced reproductive dysfunction linked to activity of the serotonin system. Fertil. Steril. 83, 148-155. doi: 10.1016/j.fertnstert.2004.06.051
20. Bethea, C. L., Streicher, J. M., Mirkes, S. J., Sanchez, R. L., Reddy, A. P., and Cameron, J. L. (2005b). Serotonin-related gene expression in female monkeys with individual sensitivity to stress. Neuroscience 132, 151-166. doi: 10.1016/j.neuroscience.2004.11.022
21. Binder, E. B., and Nemeroff, C. B. (2010). The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol. Psychiatry 15, 574-588. doi: 10.1038/mp.2009.141
22. Bittencourt, J. C., and Sawchenko, P. E. (2000). Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system. J. Neurosci. 20, 1142-1156.
23. Bittencourt, J. C., Vaughan, J., Arias, C., Rissman, R. A., Vale, W. W., and Sawchenko, P. E. (1999). Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 crf receptors. J. Comp. Neurol. 415, 285-312. doi: 10.1002/(SICI)1096-9861(19991220)415:3<285::AID-CNE1>3.0.CO;2-0
24. Boldrini, M., Underwood, M. D., Mann, J. J., and Arango, V. (2005). More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res. 1041, 19-28. doi: 10.1016/j.brainres.2005.01.083
25. Bonkale, W. L., Turecki, G., and Austin, M. C. (2006). Increased tryptophan hydroxylase immunoreactivity in the dorsal raphe nucleus of alcohol-dependent, depressed suicide subjects is restricted to the dorsal subnucleus. Synapse 60, 81-85. doi: 10.1002/syn.20278
26. Bouwknecht, J. A., Spiga, F., Staub, D. R., Hale, M. W., Shekhar, A., and Lowry, C. A. (2007). Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors: relationship to c-Fos expression in serotonergic and non-serotonergic neurons in the dorsal raphe nucleus. Brain Res. Bull. 72, 32-43. doi: 10.1016/j.brainresbull.2006.12.009
27. Breu, J., Touma, C., Hölter, S. M., Knapman, A., Wurst, W., and Deussing, J. M. (2012). Urocortin 2 modulates aspects of social behaviour in mice. Behav. Brain Res. 233, 331-336. doi: 10.1016/j.bbr.2012.05.031
28. Calandreau, L., Jaffard, R., and Desmedt, A. (2007). Dissociated roles for the lateral and medial septum in elemental and contextual fear conditioning. Learn. Mem. 14, 422-429. doi: 10.1101/lm.531407
29. Campbell, B. M., and Merchant, K. M. (2003). Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment. Brain Res. 993, 1-9. doi: 10.1016/S0006-8993(03)03384-5
30. Canteras, N. S., Shammah-Lagnado, S. J., Silva, B. A., and Ricardo, J. A. (1990). Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 513, 43-59. doi: 10.1016/0006-8993(90)91087-W
31. Chalmers, D., Lovenberg, T., and De Souza, E. (1995). Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15, 6340-6350.
32. Cheeta, S., Kenny, P. J., and File, S. E. (2000). Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog. Neuropsychopharmacol. Biol. Psychiatry 24, 1053-1067. doi: 10.1016/S0278-5846(00)00129-9
33. Chen, A., Zorrilla, E., Smith, S., Rousso, D., Levy, C., Vaughan, J., et al. (2006). Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. J. Neurosci. 26, 5500-5510. doi: 10.1523/JNEUROSCI.3955-05.2006
34. Commons, K. G., Connolley, K. R., and Valentino, R. J. (2003). A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology 28, 206-215. doi: 10.1038/sj.npp.1300045
35. Coste, S. C., Heard, A. D., Phillips, T. J., and Stenzel-Poore, M. P. (2006). Corticotropin-releasing factor receptor type 2-deficient mice display impaired coping behaviors during stress. Genes Brain Behav. 5, 131-138. doi: 10.1111/j.1601-183X.2005.00142.x
36. Coste, S. C., Kesterson, R. A., Heldwein, K. A., Stevens, S. L., Heard, A. D., Hollis, J. H., et al. (2000). Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 24, 403-409. doi: 10.1038/74255
37. Dautzenberg, F. M., Kilpatrick, G. J., Hauger, R. L., and Moreau, J.-L. (2001). Molecular biology of the CRH receptors- in the mood. Peptides 22, 753-760. doi: 10.1016/S0196-9781(01)00388-6
38. Davis, M. (1997). Neurobiology of fear responses: the role of the amygdala. J. Neuropsychiatry Clin. Neurosci. 9, 382-402.
39. Davis, M., Walker, D., Miles, L. A., and Grillon, C. (2010). Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35, 105-135. doi: 10.1038/npp.2009.109
40. Day, H. E., Greenwood, B. N., Hammack, S. E., Watkins, L. R., Fleshner, M., Maier, S. F., et al. (2004). Differential expression of 5HT-1A, a1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, ?-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J. Comp. Neurol. 3, 364-378. doi: 10.1002/cne.20138
41. De Bellis, M. D., Gold, P. W., Geracioti, T. D. J., Listwak, S. J., and Kling, M. A. (1993). Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am. J. Psychiatry 150, 656-657.
42. De Groote, L., Peñalva, R. G., Flachskamm, C., Reul, J. M. H. M., and Linthorst, A. C. E. (2005). Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists. J. Neurochem. 94, 45-56. doi: 10.1111/j.1471-4159.2005.03164.x
43. de Paula, D. C., Torricelli, A. S., Lopreato, M. R., Nascimento, J. O. G., and Viana, M. B. (2012). 5-HT2A receptor activation in the dorsolateral septum facilitates inhibitory avoidance in the elevated T-maze. Behav. Brain Res. 226, 50-55. doi: 10.1016/j.bbr.2011.08.044
44. Deussing, J. M., Breu, J., Kühne, C., Kallnik, M., Bunck, M., Glasl, L., et al. (2010). Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2. J. Neurosci. 30, 9103-9116. doi: 10.1523/JNEUROSCI.1049-10.2010
45. Donaldson, C. J., Sutton, S. W., Perrin, M. H., Corrigan, A. Z., Lewis, K. A., Rivier, J. E., et al. (1996). Cloning and characterization of human urocortin. Endocrinology 137, 2167-2170. doi: 10.1210/en.137.5.2167
46. Dong, H. W., Petrovich, G. D., and Swanson, L. W. (2001). Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res. Brain Res. Rev. 38, 192-246. doi: 10.1016/S0165-0173(01)00079-0
47. Dong, H. W., and Swanson, L. W. (2004). Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis. J. Comp. Neurol. 468, 277-298. doi: 10.1002/cne.10949
48. Donner, N., Johnson, P., Fitz, S., Kellen, K., Shekhar, A., and Lowry, C. (2012a). Elevated tph2 mRNA expression in a rat model of chronic anxiety. Depress. Anxiety. 29, 307-319. doi: 10.1002/da.21925
49. Donner, N. C., Montoya, C. D., Lukkes, J. L., and Lowry, C. A. (2012b). Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression. Psychoneuroendocrinology 37, 645-661. doi: 10.1016/j.psyneuen.2011.08.008
50. Dunn, A. J., and Berridge, C. W. (1990). Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Brain Res. Rev. 15, 71-100. doi: 10.1016/0165-0173(90)90012-D
51. Erb, S., and Stewart, J. (1999). A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J. Neurosci. 19, 35RC.
52. Eriksson, T. M., Holst, S., Stan, T. L., Hager, T., Sjögren, B., ögren, S. O., et al. (2012). 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors. Neuropharmacology 63, 1150-1160. doi: 10.1016/j.neuropharm.2012.06.061
53. Feinstein, J. S., Buzza, C., Hurlemann, R., Follmer, R. L., Dahdaleh, N. S., Coryell, W. H., et al. (2013). Fear and panic in humans with bilateral amygdala damage. Nat. Neurosci. 16, 270-272. doi: 10.1038/nn.3323
54. Fekete, é. M., and Zorrilla, E. P. (2007). Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front. Neuroendocrinol. 28, 1-27. doi: 10.1016/j.yfrne.2006.09.002
55. Forster, G. L., Feng, N., Watt, M. J., Korzan, W. J., Mouw, N. J., Summers, C. H., et al. (2006). Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience 141, 1047-1055. doi: 10.1016/j.neuroscience.2006.04.006
56. Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., et al. (2010). Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 303, 47-53. doi: 10.1001/jama.2009.1943
57. Fulford, A. J., and Marsden, C. A. (1997). Conditioned release of 5-hydroxytryptamine in vivo in the nucleus accumbens following isolation-rearing in the rat. Neuroscience 83, 481-487. doi: 10.1016/S0306-4522(97)00423-5
58. Fulford, A. J., and Marsden, C. A. (2007). An intact dopaminergic system is required for context-conditioned release of 5-HT in the nucleus accumbens of postweaning isolation-reared rats. Neuroscience 149, 392-400. doi: 10.1016/j.neuroscience.2007.08.002
59. Funk, D., Li, Z., and Lê, A. D. (2006). Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: relationship to the reinstatement of alcohol seeking. Neuroscience 138, 235-243. doi: 10.1016/j.neuroscience.2005.10.062
60. Gardner, K. L., Hale, M. W., Oldfield, S., Lightman, S. L., Plotsky, P. M., and Lowry, C. A. (2009). Adverse experience during early life and adulthood interact to elevate tph2 mRNA expression in serotonergic neurons within the dorsal raphe nucleus. Neuroscience 163, 991-1001. doi: 10.1016/j.neuroscience.2009.07.055
61. Gardner, K. L., Thrivikraman, K. V., Lightman, S. L., Plotsky, P. M., and Lowry, C. A. (2005). Early life experience alters behavior during social defeat: focus on serotonergic systems. Neuroscience 136, 181-191. doi: 10.1016/j.neuroscience.2005.07.042
62. Gibbons, R. D., Hur, K., Brown, C., Davis, J. M., and Mann, J. (2012). Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch. Gen. Psychiatry 69, 572-579. doi: 10.1001/archgenpsychiatry.2011.2044
63. Goetz, R. R., Klein, D. F., Papp, L. A., Martinez, J. M., and Gorman, J. M. (2001). Acute panic inventory symptoms during CO2 inhalation and room-air hyperventilation among panic disorder patients and normal controls. Depress. Anxiety 14, 123-136. doi: 10.1002/da.1054
64. Goldstein, B. J., and Goodnick, P. J. (1998). Selective serotonin reuptake inhibitors in the treatment of affective disorders-III. Tolerability, safety and pharmacoeconomics. J. Psychopharmacol. 12(3 Suppl. B), S55-S87.
65. Gray, T. S. (1993). Amygdaloid CRF pathways: role in autonomic, neuroendocrine, and behavioral responses to stress. Ann. NY. Acad. Sci. 697, 53-60
66. Greenwood, B., Foley, T. E., Day, H., Burhans, D., Brooks, L., Campaeu, S., et al. (2005). Wheel running alters serotonin (5-HT) transporter, 5-HT(1a), 5-HT(1b), and alpha(1b)-adrenergic receptor mRNA in the rat raphe nuclei. Biol. Psychiatry 57, 559-568. doi: 10.1016/j.biopsych.2004.11.025
67. Greenwood, B., Foley, T. E., Day, H. E., Campisi, J., Hammack, S. H., Campeau, S., et al. (2003). Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J. Neurosci. 23, 2889-2898.
68. Greenwood, B. N., Strong, P. V., Loughridge, A. B., Day, H. E. W., Clark, P. J., Mika, A., et al. (2012). 5-HT2C receptors in the basolateral amygdala and dorsal striatum are a novel target for the anxiolytic and antidepressant effects of exercise. PLoS ONE 7:e46118. doi: 10.1371/journal.pone.0046118
69. Grove, E. A. (1998). Neural associations of the substantia innominata in the rat: afferent connections. J. Comp. Neurol. 15, 35-46.
70. Guo, J. D., Hammack, S. E., Hazra, R., Levita, L., and Rainnie, D. G. (2009). Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes. Neuroscience 164, 1776-1793. doi: 10.1016/j.neuroscience.2009.09.028
71. Guo, J. D., and Rainnie, D. G. (2010). Presynaptic 5-HT1B receptor-mediated serotonergic inhibition of glutamate transmission in the bed nucleus of the stria terminalis. Neuroscience 165, 1390-1401. doi: 10.1016/j.neuroscience.2009.11.071
72. Hale, M., Shekhar, A., and Lowry, C. (2012). Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. Cell. Mol. Neurobiol. 32, 695-708. doi: 10.1007/s10571-012-9827-1
73. Hale, M. W., Dady, K. F., Evans, A. K., and Lowry, C. A. (2011). Evidence for in vivo thermosensitivity of serotonergic neurons in the rat dorsal raphe nucleus and raphe pallidus nucleus implicated in thermoregulatory cooling. Exp. Neurol. 227, 264-278. doi: 10.1016/j.expneurol.2010.11.012
74. Hale, M. W., Hay-Schmidt, A., Mikkelsen, J. D., Poulsen, B., Bouwknecht, J. A., Evans, A. K., et al. (2008). Exposure to an open-field arena increases c-Fos expression in a subpopulation of neurons in the dorsal raphe nucleus, including neurons projecting to the basolateral amygdaloid complex. Neuroscience 157, 733-748. doi: 10.1016/j.neuroscience.2008.09.050
75. Hale, M. W., and Lowry, C. A. (2011). Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits. Psychopharmacology 213, 243-264. doi: 10.1007/s00213-010-2089-z
76. Hale, M. W., Stamper, C. E., Staub, D. R., and Lowry, C. A. (2010). Urocortin 2 increases c-Fos expression in serotonergic neurons projecting to the ventricular/periventricular system. Exp. Neurol. 224, 271-281. doi: 10.1016/j.expneurol.2010.04.002
77. Hammack, S. E., Guo, J.-D., Hazra, R., Dabrowska, J., Myers, K. M., and Rainnie, D. G. (2009). The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 1309-1320. doi: 10.1016/j.pnpbp.2009.05.013
78. Hammack, S. E., Pepin, J. L., DesMarteau, J. S., Watkins, L. R., and Maier, S. F. (2003a). Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress. Behav. Brain Res. 147, 55-64. doi: 10.1016/S0166-4328(03)00133-5
79. Hammack, S. E., Schmid, M. J., LoPresti, M. L., Der-Avakian, A., Pellymounter, M. A., Foster, A. C., et al. (2003b). Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J. Neurosci. 23, 1019-1025.
80. Hammack, S. E., Richey, K. J., Schmid, M. J., LoPresti, M. L., Watkins, L. R., and Maier, S. F. (2002). The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. J. Neurosci. 22, 1020-1026.
81. Hammack, S. E., Richey, K. J., Watkins, L. R., and Maier, S. F. (2004). Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress. Behav. Neurosci. 118, 443-448. doi: 10.1037/0735-7044.118.2.443
82. Hannon, J., and Hoyer, D. (2008). Molecular biology of 5-HT receptors. Behav. Brain Res. 195, 198-213. doi: 10.1016/j.bbr.2008.03.020
83. Heinrichs, S. C., Min, H., Tamraz, S., Carmouché, M., Boehme, S. A., and Vale, W. W. (1997). Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated. Psychoneuroendocrinology 22, 215-224. doi: 10.1016/S0306-4530(97)00030-9
84. Herod, S. M., Dettmer, A. M., Novak, M. A., Meyer, J. S., and Cameron, J. L. (2011a). Sensitivity to stress-induced reproductive dysfunction is associated with a selective but not a generalized increase in activity of the adrenal axis. Am. J. Physiol. Endocrinol. Metab. 300, E28-E36. doi: 10.1152/ajpendo.00223.2010
85. Herod, S. M., Pohl, C. R., and Cameron, J. L. (2011b). Treatment with a CRH-R1 antagonist prevents stress-induced suppression of the central neural drive to the reproductive axis in female macaques. Am. J. Physiol. Endocrinol. Metab. 300, E19-E27. doi: 10.1152/ajpendo.00224.2010
86. Hollis, J. H., Evans, A. K., Bruce, K. P. E., Lightman, S. L., and Lowry, C. A. (2006). Lipopolysaccharide has indomethacin-sensitive actions on Fos expression in topographically organized subpopulations of serotonergic neurons. Brain Behav. Immun. 20, 569-577. doi: 10.1016/j.bbi.2006.01.006
87. Holstege, G. (1995). The Basic, Somatic, and Emotional Components of the Motor System in Mammals. Vol. 137-154. San Diego, CA: Academic.
88. Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., et al. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 46, 157-203.
89. Hoyer, D., Hannon, J. P., and Martin, G. R. (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71, 533-554. doi: 10.1016/S0091-3057(01)00746-8
90. Hurley, K. M., Herbert, H., Moga, M. M., and Saper, C. B. (1991). Efferent projections of the infralimbic cortex of the rat. J. Comp. Neurol. 308, 249-276. doi: 10.1002/cne.903080210
91. Imai, H., Steindler, D. A., and Kitai, S. T. (1986). The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol. 243, 363-380. doi: 10.1002/cne.902430307
92. Johnson, P., Lowry, C., Truitt, W., and Shekhar, A. (2008). Disruption of GABAergic tone in the dorsomedial hypothalamus attenuates responses in a subset of serotonergic neurons in the dorsal raphe nucleus following lactate-induced panic. J. Psychopharmacol. 22, 642-652. doi: 10.1177/0269881107082900
93. Johnson, P. L., Hollis, J. H., Moratalla, R., Lightman, S. L., and Lowry, C. A. (2005). Acute hypercarbic gas exposure reveals functionally distinct subpopulations of serotonergic neurons in rats. J. Psychopharmacol. 19, 327-341. doi: 10.1177/0269881105053281
94. Kagamiishi, Y., Yamamoto, T., and Watanabe, S. (2003). Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotropin-releasing factor. Brain Res. 991, 212-221. doi: 10.1016/j.brainres.2003.08.021
95. Kazakov, V. N., Kravtsov, P. Y., Krakhotkina, E. D., and Maisky, V. A. (1993). Sources of cortical, hypothalamic and spinal serotonergic projections: topical organization within the nucleus raphe dorsalis. Neuroscience 56, 157-164. doi: 10.1016/0306-4522(93)90570-6
96. Kelly, K. J., Donner, N. C., Hale, M. W., and Lowry, C. A. (2011). Swim stress activates serotonergic and nonserotonergic neurons in specific subdivisions of the rat dorsal raphe nucleus in a temperature-dependent manner. Neuroscience 197, 251-268. doi: 10.1016/j.neuroscience.2011.09.011
97. Kerman, I. A., Shabrang, C., Taylor, L., Akil, H., and Watson, S. J. (2006). Relationship of presympathetic-premotor neurons to the serotonergic transmitter system in the rat brainstem. J. Comp. Neurol. 499, 882-896. doi: 10.1002/cne.21129
98. Kim, M.-A., Lee, H. S., Lee, B. Y., and Waterhouse, B. D. (2004). Reciprocal connections between subdivisions of the dorsal raphe and the nuclear core of the locus coeruleus in the rat. Brain Res. 1026, 56-67. doi: 10.1016/j.brainres.2004.08.022
99. Kirby, L. G., Rice, K. C., and Valentino, R. J. (2000). Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22, 148-162. doi: 10.1016/S0893-133X(99)00093-7
100. Kirifides, M. L., Simpson, K. L., Lin, R. C. S., and Waterhouse, B. D. (2001). Topographic organization and neurochemical identity of dorsal raphe neurons that project to the trigeminal somatosensory pathway in the rat. J. Comp. Neurol. 435, 325-340. doi: 10.1002/cne.1033
101. Kohler, C., Chan-Palay, V., and Steinbusch, H. W. M. (1982). The distribution and origin of serotonin-containing fibers in the septal area: a combined immunohistochemical and fluorescent retrograde tracing study in the rat. J. Comp. Neurol. 209, 91-111. doi: 10.1002/cne.902090109
102. Kohler, C., and Steinbusch, H. W. M. (1982). Identification of serotonin and non-serotonin-containing neurons of the mid-brain raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain. Neuroscience 7, 951-975. doi: 10.1016/0306-4522(82)90054-9
103. Korosi, A., Veening, J. G., Kozicz, T., Henckens, M., Dederen, J., Groenink, L., et al. (2006). Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. Brain Res. 1072, 46-54. doi: 10.1016/j.brainres.2005.12.034
104. Kozicz, T. (2007). On the role of urocortin 1 in the non-preganglionic Edinger-Westphal nucleus in stress adaptation. Gen. Comp. Endocrinol. 153, 235-240. doi: 10.1016/j.ygcen.2007.04.005
105. Kozicz, T., Korosi, A., Korsman, C., Tilburg-Ouwens, D., Groenink, L., Veening, J., et al. (2004). Urocortin expression in the Edinger-Westphal nucleus is down-regulated in transgenic mice over-expressing neuronal corticotropin-releasing factor. Neuroscience 123, 589-594. doi: 10.1016/j.neuroscience.2003.10.042
106. Kozicz, T., Tilburg-Ouwens, D., Faludi, G., Palkovits, M., and Roubos, E. (2008). Gender-related urocortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression. Neuroscience 152, 1015-1023. doi: 10.1016/j.neuroscience.2007.12.050
107. Kozicz, T., Yanaihara, H., and Arimura, A. (1998). Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J. Comp. Neurol. 391, 1-10. doi: 10.1002/(SICI)1096-9861(19980202)391:1<1::AID-CNE1>3.0.CO;2-6
108. Krout, K. E., Belzer, R. E., and Loewy, A. D. (2002). Brainstem projections to midline and intralaminar thalamic nuclei of the rat. J. Comp. Neurol. 448, 53-101. doi: 10.1002/cne.10236
109. Künzel, H. E., Zobel, A. W., Nickel, T., Ackl, N., Uhr, M., Sonntag, A., et al. (2003). Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects. J. Psychiatr. Res. 37, 525-533. doi: 10.1016/S0022-3956(03)00070-0
110. Kuperman, Y., Issler, O., Regev, L., Musseri, I., Navon, I., Neufeld-Cohen, A., et al. (2010). Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis. Proc. Natl. Acad. Sci. U.S.A. 107, 8393-8398. doi: 10.1073/pnas.1003969107
111. Lee, H. S., Eum, Y. J., Jo, S. M., and Waterhouse, B. D. (2007). Projection patterns from the amygdaloid nuclear complex to subdivisions of the dorsal raphe nucleus in the rat. Brain Res. 1143, 116-125. doi: 10.1016/j.brainres.2007.01.081
112. Lee, H. S., Kim, M.-A., Valentino, R. J., and Waterhouse, B. D. (2003). Glutamatergic afferent projections to the dorsal raphe nucleus of the rat. Brain Res. 963, 57-71. doi: 10.1016/S0006-8993(02)03841-6
113. Levita, L., Hammack, S. H., Mania, I., Li, X.-Y., Davis, M., and Rainnie, D. G. (2004). 5-hydroxytryptamine 1A- like receptor activation in the bed nucleus of the stria terminalis: elctrophysiological and behaviroal studies. Neuroscience 128, 583-596. doi: 10.1016/j.neuroscience.2004.06.037
114. Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., et al. (2001). Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 98, 7570-7575. doi: 10.1073/pnas.121165198
115. Li, C., Vaughan, J., Sawchenko, P. E., and Vale, W. W. (2002). Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J. Neurosci. 22, 991-1001.
116. Li, Q., Luo, T., Jiang, X., and Wang, J. (2012). Anxiolytic effects of 5-HT1A receptors and anxiogenic effects of 5-HT2C receptors in the amygdala of mice. Neuropharmacology 62, 474-484. doi: 10.1016/j.neuropharm.2011.09.002
117. Lima, F. B., Centeno, M. L., Costa, M. E., Reddy, A. P., Cameron, J. L., and Bethea, C. L. (2009). Stress sensitive female macaques have decreased fifth Ewing variant (Fev) and serotonin-related gene expression that is not reversed by citalopram. Neuroscience 164, 676-691. doi: 10.1016/j.neuroscience.2009.08.010
118. Linthorst, A. C. E., Flachskamm, C., Hopkins, S. J., Hoadley, M. E., Labeur, M. S., Holsboer, F., et al. (1997). Long-Term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J. Neurosci. 17, 4448-4460.
119. Linthorst, A. C. E., Peñalva, R. G., Flachskamm, C., Holsboer, F., and Reul, J. M. H. M. (2002). Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism. Eur. J. Neurosci. 16, 2441-2452. doi: 10.1046/j.1460-9568.2002.02400.x
120. Ljubic-Thibal, V., Morin, A., Diksic, M., and Hamel, E. (1999). Origin of the serotonergic innervation to the rat dorsolateral hypothalamus: retrograde transport of cholera toxin and upregulation of tryptophan hydroxylase mRNA expression following selective nerve terminals lesion. Synapse 32, 177-186. doi: 10.1002/(SICI)1098-2396(19990601)32:3<177::AID-SYN4>3.0.CO;2-D
121. Lovejoy, D. A., and Jahan, S. (2006). Phylogeny of the corticotropin-releasing factor family of peptides in the metazoa. Gen. Comp. Endocrinol. 146, 1-8. doi: 10.1016/j.ygcen.2005.11.019
122. Lovenberg, T. W., Liaw, C. W., Grigoriadis, D. E., Clevenger, W., Chalmers, D. T., De Souza, E. B., et al. (1995). Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U.S.A. 92, 836-840. doi: 10.1073/pnas.92.3.836
123. Lowry, C. A. (2002). Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J. Neuroendocrinol. 14, 911-923. doi: 10.1046/j.1365-2826.2002.00861.x
124. Lowry, C. A., Hale, M. W., Evans, A. K., Heerkens, J., Staub, D. R., Gasser, P. J., et al. (2008). Serotonergic systems, anxiety, and affective disorder. Ann. N.Y. Acad. Sci. 1148, 86-94. doi: 10.1196/annals.1410.004
125. Lowry, C. A., Hollis, J. H., de Vries, A., Pan, B., Brunet, L. R., Hunt, J. R. F., et al. (2007). Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. Neuroscience 146, 756-772. doi: 10.1016/j.neuroscience.2007.01.067
126. Lowry, C. A., Johnson, P. L., Hay-Schmidt, A., Mikkelsen, J., and Shekhar, A. (2005). Modulation of anxiety circuits by serotonergic systems. Stress 8, 233-246. doi: 10.1080/10253890500492787
127. Lowry, C. A., Rodda, J. E., Lightman, S. L., and Ingram, C. D. (2000). Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J. Neurosci. 20, 7728-7736.
128. Lukkes, J. L., Forster, G. L., Renner, K. J., and Summers, C. H. (2008). Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens. Eur. J. Pharmacol. 578, 185-193. doi: 10.1016/j.ejphar.2007.09.024
129. Lukkes, J. L., Staub, D. R., Dietrich, A., Truitt, W., Neufeld-Cohen, A., Chen, A., et al. (2011). Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylase. Neuroscience 183, 47-63. doi: 10.1016/j.neuroscience.2011.03.047
130. Magierek, V., Ramos, P. L., da Silveira-Filho, N. G., Nogueira, R. L., and Landeira-Fernandez, J. (2003). Context fear conditioning inhibits panic-like behavior elicited by electrical stimulation of dorsal periaqueductal gray. Neuroreport 14, 1641-1644. doi: 10.1097/00001756-200308260-00020
131. Meloni, E. G., Reedy, C. L., Cohen, B. M., and Carlezon, W. A. Jr. (2008). Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior. Biol. Psychiatry 63, 832-839. doi: 10.1016/j.biopsych.2007.10.016
132. Mitchell, A. J. (1998). The role of corticotropin releasing factor in depressive illness: a critical review. Neurosci. Biobehav. Rev. 22, 635-651. doi: 10.1016/S0149-7634(97)00059-6
133. Muller, M. B., Zimmermann, S., Sillaber, I., Hagemeyer, T. P., Deussing, J. M., Timpl, P., et al. (2003). Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci. 6, 1100-1107. doi: 10.1038/nn1123
134. Neufeld-Cohen, A., Evans, A. K., Getselter, D., Spyroglou, A., Hill, A., Gil, S., et al. (2010a). Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits. Mol. Psychiatry 15, 426-441. doi: 10.1038/mp.2009.115
135. Neufeld-Cohen, A., Tsoory, M. M., Evans, A. K., Getselter, D., Gil, S., Lowry, C. A., et al. (2010b). A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery. Proc. Natl. Acad. Sci. U.S.A. 107, 19020-19025. doi: 10.1073/pnas.1013761107
136. Neufeld-Cohen, A., Kelly, P. A. T., Paul, E. D., Carter, R. N., Skinner, E., Olverman, H. J., et al. (2012). Chronic activation of corticotropin-releasing factor type 2 receptors reveals a key role for 5-HT1A receptor responsiveness in mediating behavioral and serotonergic responses to stressful challenge. Biol. Psychiatry 72, 437-447. doi: 10.1016/j.biopsych.2012.05.005
137. O'Hearn, E., and Molliver, M. E. (1984). Organization of raphe-cortical projections in rat: a quantitative retrograde study. Brain Res. Bull. 13, 709-726. doi: 10.1016/0361-9230(84)90232-6
138. Park, S. M., and Williams, C. L (2012). Contribution of serotonin type 3 receptors in the successful extinction of cued or contextual fear conditioned responses: interactions with GABAergic signaling. Rev. Neurosci. 23, 555-569. doi: 10.1515/revneuro-2012-0052
139. Patel, R., Spreng, R. N., Shin, L. M., and Girard, T. A. (2012). Neurocircuitry models of posttraumatic stress disorder and beyond: a meta-analysis of functional neuroimaging studies. Neurosci. Biobehav. Rev. 36, 2130-2142. doi: 10.1016/j.neubiorev.2012.06.003
140. Paul, E. D., Hale, M. W., Lukkes, J. L., Valentine, M. J., Sarchet, D. M., and Lowry, C. A. (2011). Repeated social defeat increases reactive emotional coping behavior and alters functional responses in serotonergic neurons in the rat dorsal raphe nucleus. Physiol. Behav. 104, 272-282. doi: 10.1016/j.physbeh.2011.01.006
141. Paxinos, G., and Watson, C. (1998). The Rat Brain in Stereotaxic Coordinates, 4th Edn. San Diego, CA: Academic.
142. Pentkowski, N. S., Duke, F. D., Weber, S. M., Pockros, L. A., Teer, A. P., Hamilton, E. C., et al. (2010). Stimulation of medial prefrontal cortex serotonin 2C (5-HT2C) receptors attenuates cocaine-seeking behavior. Neuropsychopharmacology 35, 2037-2048. doi: 10.1038/npp.2010.72
143. Pernar, L., Curtis, A. L., Vale, W. W., Rivier, J. E., and Valentino, R. J. (2004). Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J. Neurosci. 24, 1305-1311. doi: 10.1523/JNEUROSCI.2885-03.2004
144. Perrin, M. H., Donaldson, C. J., Chen, R., Lewis, K. A., and Vale, W. W. (1993). Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133, 3058-3061. doi: 10.1210/en.133.6.3058
145. Perrin, M. H., Grace, C. R. R., Riek, R., and Vale, W. W. (2006). The three-dimensional structure of the n-terminal domain of corticotropin-releasing factor receptors. Ann. N.Y. Acad. Sci. 1070, 105-119. doi: 10.1196/annals.1317.065
146. Petit, J.-M., Luppi, P.-H., Peyron, C., Rampon, C., and Jouvet, M. (1995). VIP-like immunoreactive projections from the dorsal raphe and caudal linear raphe nuclei to the bed nucleus of the stria terminalis demonstrated by a double immunohistochemical method in the rat. Neurosci. Lett. 193, 77-80. doi: 10.1016/0304-3940(95)11669-N
147. Peyron, C., Petit, J. M., Rampon, C., Jouvet, M., and Luppi, P. H. (1997). Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 82, 443-468. doi: 10.1016/S0306-4522(97)00268-6
148. Phelps, E. A., and LeDoux, J. E. (2005). Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48, 175-187. doi: 10.1016/j.neuron.2005.09.025
149. Porrino, L. J., and Goldman-Rakic, P. S. (1982). Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J. Comp. Neurol. 205, 63-76. doi: 10.1002/cne.902050107
150. Potter, E., Sutton, S., Donaldson, C., Chen, R., Perrin, M., Lewis, K., et al. (1994). Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. U.S.A. 91, 8777-8781. doi: 10.1073/pnas.91.19.8777
151. Price, M. L., Curtis, A. L., Kirby, L. G., Valentino, R. J., and Lucki, I. (1998). Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18, 492-502. doi: 10.1016/S0893-133X(97)00197-8
152. Price, M. L., Kirby, L. G., Valentino, R. J., and Lucki, I. (2002). Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. Psychopharmacology 162, 406-414. doi: 10.1007/s00213-002-1114-2
153. Price, M. L., and Lucki, I. (2001). Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J. Neurosci. 21, 2833-2841.
154. Rainnie, D. G. (1999). Serotonergic modulation of neurotransmission in the rat basolateral amygdala. J. Neurophysiol. 82, 69-85.
155. Ressler, K. J., and Nemeroff, C. B. (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress. Anxiety 12(Suppl. 1), 2-19. doi: 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4
156. Reul, J. M. H. M., and Holsboer, F. (2002). Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2, 23-33. doi: 10.1016/S1471-4892(01)00117-5
157. Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., et al. (2001). Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 2843-2848. doi: 10.1073/pnas.051626398
158. Roberts, A. J., Krucker, T., Levy, C. L., Slanina, K. A., Sutcliffe, J. G., and Hedlund, P. B. (2004). Mice lacking 5-HT7 receptors show specific impairments in contextual learning. Eur. J. Neurosci. 19, 1913-1922. doi: 10.1111/j.1460-9568.2004.03288.x
159. Roche, M., Commons, K. G., Peoples, A., and Valentino, R. J. (2003). Circuitry underlying regulation of the serotonergic system by swim stress. J. Neurosci. 23, 970-977.
160. Rozeske, R. R., Evans, A. K., Frank, M. G., Watkins, L. R., Lowry, C. A., and Maier, S. F. (2011). Uncontrollable, but not controllable, stress desensitizes 5-ht1a receptors in the dorsal raphe nucleus. J. Neurosci. 31, 14107-14115. doi: 10.1523/JNEUROSCI.3095-11.2011
161. Ruggiero, D. A., Underwood, M. D., Rice, P. M., Mann, J. J., and Arango, V. (1999). Corticotropic-releasing hormone and serotonin interact in the human brainstem: behavioral implications. Neuroscience 91, 1343-1354. doi: 10.1016/S0306-4522(98)00703-9
162. Sakanaka, M., Shibasaki, T., and Lederis, K. (1987). Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J. Comp. Neurol. 260, 256-298. doi: 10.1002/cne.902600209
163. Salam, J. N., Fox, J. H., DeTroy, E. M., Guignon, M. H., Wohl, D. F., and Falls, W. A. (2009). Voluntary exercise in C57 mice is anxiolytic across several measures of anxiety. Behav. Brain Res. 197, 31-40. doi: 10.1016/j.bbr.2008.07.036
164. Saper, C. B., and Loewy, A. D. (1980). Efferent connections of the parabrachial nucleus in the rat. Brain Res. 197, 291-317. doi: 10.1016/0006-8993(80)91117-8
165. Scholl, J. L., Vuong, S. M., and Forster, G. L. (2010). Chronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdala. Eur. J. Pharmacol. 644, 80-87. doi: 10.1016/j.ejphar.2010.07.008
166. Senashova, O., Reddy, A. P., Cameron, J. L., and Bethea, C. L. (2012). The effect of citalopram on midbrain crf receptors 1 and 2 in a primate model of stress-induced amenorrhea. Reprod. Sci. 19, 623-632. doi: 10.1177/1933719111430992
167. Shen, H., and Semba, K. (1994). A direct retinal projection to the dorsal raphe nucleus in the rat. Brain Res. 635, 159-168. doi: 10.1016/0006-8993(94)91435-4
168. Shen, R.-Y., and Andrade, R. (1998). 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus. J. Pharmacol. Exp. Ther. 285, 805-812.
169. Sink, K. S., Walker, D. L., Freeman, S. M., Flandreau, E. I., Ressler, K. J., and Davis, M. (2013). Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety. Mol. Psychiatry 18, 308-319. doi: 10.1038/mp.2011.188
170. Smith, G. W., Aubry, J.-M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., et al. (1998). Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20, 1093-1102. doi: 10.1016/S0896-6273(00)80491-2
171. Smythies, J. (2005). "Section V. Serotonin System," in International Review of Neurobiology, Vol. 64, ed J. Smythies (Waltham, MA: Academic Press), 217-268.
172. Staub, D. R., Evans, A. K., and Lowry, C. A. (2006). Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons. Brain Res. 1070, 77-89. doi: 10.1016/j.brainres.2005.10.096
173. Staub, D. R., Spiga, F., and Lowry, C. A. (2005). Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus. Brain Res. 1044, 176-189. doi: 10.1016/j.brainres.2005.02.080
174. Steinbusch, H. W. M. (1981). Distribution of serotonin-immunoreactivity in the central nervous system of the rat-Cell bodies and terminals. Neuroscience 6, 557-618. doi: 10.1016/0306-4522(81)90146-9
175. Steinbusch, H. W. M., van der Kooy, D., Verhofstad, A. A., and Pellegrino, A. (1980). Serotonergic and non-serotonergic projections from the nucleus raphe dorsalis to the caudate-putamen complex in the rat, studied by a combined immunofluorescence and fluorescent retrograde axonal labeling technique. Neurosci. Lett. 19, 137-142. doi: 10.1016/0304-3940(80)90184-6
176. Stenzel-Poore, M., Heinrichs, S., Rivest, S., Koob, G., and Vale, W. (1994). Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14, 2579-2584.
177. Stezhka, V. V., and Lovick, T. A. (1997). Projections from dorsal raphe nucleus to the periaqueductal grey matter: studies in slices of rat midbrain maintained in vitro. Neurosci. Lett. 230, 57-60. doi: 10.1016/S0304-3940(97)00464-3
178. Stiedl, O., Misane, I., Spiess, J., and ögren, S. O. (2000). Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice. J. Neurosci. 20, 8515-8527.
179. Swanson, L. W., Sawchenko, P. E., Rivier, J., and Vale, W. W. (1983). Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36, 165-186. doi: 10.1159/000123454
180. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., et al. (1998). Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19, 162-166. doi: 10.1038/520
181. Underwood, M. D., Arango, V., Bakalian, M. J., Ruggiero, D. A., and Mann, J. J. (1999). Dorsal raphe nucleus serotonergic neurons innervate the rostral ventrolateral medulla in rat. Brain Res. 824, 45-55. doi: 10.1016/S0006-8993(99)01181-6
182. Vale, W. W., Rivier, C., Brown, M. R., Spiess, J., Koob, G., Swanson, L., et al. (1983). Chemical and biological characterization of corticotropin releasing factor. Recent Prog. Horm. Res. 39, 245-270.
183. Vale, W. W., Spiess, J., Rivier, C., and Rivier, J. (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 1394-1397. doi: 10.1126/science.6267699
184. Valentino, R. J., Liouterman, L., and Van Bockstaele, E. J. (2001). Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus. J. Comp. Neurol. 435, 450-463. doi: 10.1002/cne.1043
185. Van Bockstaele, E. J., Biswas, A., and Pickel, V. M. (1993). Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens. Brain Res. 624, 188-198. doi: 10.1016/0006-8993(93)90077-Z
186. van Gaalen, M. M., Stenzel-Poore, M. P., Holsboer, F., and Steckler, T. (2002). Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur. J. Neurosci. 15, 2007-2015. doi: 10.1046/j.1460-9568.2002.02040.x
187. Van Pett, K., Viau, V., Bittencourt, J. C., Chan, R. K. W., Li, H.-Y., Arias, C., et al. (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428, 191-212. doi: 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U
188. Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S. W., et al. (1995). Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287-292. doi: 10.1038/378287a0
189. Vetter, D. E., Li, C., Zhao, L., Contarino, A., Liberman, M. C., Smith, G. W., et al. (2002). Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat. Genet. 31, 363-369. doi: 10.1038/ng914
190. Wang, L., Goebel-Stengel, M., Stengel, A., Wu, S. V., Ohning, G., and Taché, Y. (2011). Comparison of CRF-immunoreactive neurons distribution in mouse and rat brains and selective induction of Fos in rat hypothalamic CRF neurons by abdominal surgery. Brain Res. 1415, 34-46. doi: 10.1016/j.brainres.2011.07.024
191. Wang, X., Su, H., Copenhagen, L. D., Vaishnav, S., Pieri, F., Shope, C. D., et al. (2002). Urocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle response. Mol. Cell. Biol. 22, 6605-6610. doi: 10.1128/MCB.22.18.6605-6610.2002
192. Waselus, M., Nazzaro, C., Valentino, R. J., and Van Bockstaele, E. J. (2009). Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus. Biol. Psychiatry 66, 76-83. doi: 10.1016/j.biopsych.2009.02.014
193. Waterhouse, B. D., Border, B., Wahl, L., and Mihailoff, G. A. (1993). Topographic organization of rat locus coeruleus and dorsal raphe nuclei: distribution of cells projecting to visual system structures. J. Comp. Neurol. 336, 345-361. doi: 10.1002/cne.903360304
194. Waterhouse, B. D., Mihailoff, G. A., Baack, J. C., and Woodward, D. J. (1986). Topographical distribution of dorsal and median raphe neurons projecting to motor, sensorimotor, and visual cortical areas in the rat. J. Comp. Neurol. 249, 460-476, 478-481. doi: 10.1002/cne.902490403
195. Weissheimer, K. V., Herod, S. M., Cameron, J. L., and Bethea, C. L. (2010). Interactions of corticotropin-releasing factor, urocortin and citalopram in a primate model of stress-induced amenorrhea. Neuroendocrinology 92, 224-234. doi: 10.1159/000319257
196. Weninger, S. C., Peters, L. L., and Majzoub, J. A. (2000). Urocortin expression in the edinger-westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency. Endocrinology 141, 256-263. doi: 10.1210/en.141.1.256
197. Zayara, A., McIver, G., Valdivia, P., Lominac, K., McCreary, A., and Szumlinski, K. (2011). Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats. Psychopharmacology 213, 321-335. doi: 10.1007/s00213-010-1996-3
198. Zhao, L., Donaldson, C. J., Smith, G. W., and Vale, W. W. (1998). The structures of the mouse and human urocortin genes (Ucn and UCN). Genomics 50, 23-33. doi: 10.1006/geno.1998.5292